Panangin 158 mg/140 mg apvalkotās tabletes Latvija - latvių - Zāļu valsts aģentūra

panangin 158 mg/140 mg apvalkotās tabletes

gedeon richter plc., hungary - kalii aspartas, magnija aspartas - apvalkotā tablete - 158 mg/140 mg

Longosona 1 mg/ml suspensija injekcijām Latvija - latvių - Pārtikas un veterinārais dienests, Zemkopības ministrija

longosona 1 mg/ml suspensija injekcijām

industrial veterinaria, s.a. - invesa, spānija - deksametazona isonicotinate - suspensija injekcijām - 1 mg/ml - aitas; cūkas; liellopi; zirgi

Dophalin Latvija - latvių - Pārtikas un veterinārais dienests, Zemkopības ministrija

dophalin

vetpharma animal health, s.l., spānija - lincomycin - pulveris lietošanai ar dzeramo ūdeni - 400 mg/g - vistas

Vaminolact šķīdums infūzijām Latvija - latvių - Zāļu valsts aģentūra

vaminolact šķīdums infūzijām

fresenius kabi ab, sweden - alaninum, argininum, skābes asparticum, skābes glutamicum, glycinum, histidinum, isoleucinum, cysteinum, leucinum, lysinum, methioninum, phenylalaninum, prolinum, serinum, liellopu gaļas, threoninum, tryptophanum, tyrosinum, valinum - Šķīdums infūzijām

Kymriah Europos Sąjunga - latvių - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - other antineoplastic agents - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Delstrigo Europos Sąjunga - latvių - EMA (European Medicines Agency)

delstrigo

merck sharp & dohme b.v. - doravirine, lamivudīnu, tenofovir disoproxil fumarate - hiv infekcijas - antivirals for treatment of hiv infections, combinations - delstrigo ir indicēts, lai ārstētu pieaugušos ar hiv inficēti 1 bez pagātnes vai tagadnes pierādījumus par pretestību nnrti klases, lamivudīnu, vai tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Pifeltro Europos Sąjunga - latvių - EMA (European Medicines Agency)

pifeltro

merck sharp & dohme b.v. - doravirine - hiv infekcijas - pretvīrusu līdzekļi sistēmiskai lietošanai - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.

Panangin 316 mg/280 mg apvalkotās tabletes Latvija - latvių - Zāļu valsts aģentūra

panangin 316 mg/280 mg apvalkotās tabletes

gedeon richter plc., hungary - kalii aspartas, magnija aspartas - apvalkotā tablete - 316 mg/280 mg

Dexamethasone Kalceks 4 mg/ml šķīdums injekcijām/infūzijām Latvija - latvių - Zāļu valsts aģentūra

dexamethasone kalceks 4 mg/ml šķīdums injekcijām/infūzijām

kalceks, a/s, latvia - deksametazona fosfāts - Šķīdums injekcijām/infūzijām - 4 mg/ml

Dimethyl fumarate Neuraxpharm Europos Sąjunga - latvių - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimethyl fumarate - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.